-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Earlier: Johnson & Johnson Secures Permanent J-Code For INLEXZO, Streamlining Billing For BCG-Unresponsive Bladder Cancer Therapy

Benzinga·04/01/2026 16:51:42
Listen to the news